Watson David O.
CIK 1657719
Transactions on file
32
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 7,363 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 6,001 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 11,874 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 55,986 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 32,072 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 55,986 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Grant | 55,986 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 27,993 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Grant | 27,993 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 28,508 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Grant | 28,508 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Disp. | 41,250 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | Grant | 41,250 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | U | 50,136 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | U | 10,000 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-14 | APLS Apellis Pharmaceuticals, Inc. | General Counsel | U | 144,517 | $0.00 | — | open → |
| 2025-01-14 | 2025-01-13 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 4,965 | $142.5K | -87.5% | open → |
| 2025-01-21 | 2025-01-17 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 2,201 | $65.9K | -88.0% | open → |
| 2025-01-21 | 2025-01-21 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Grant | 42,762 | $0.00 | — | open → |
| 2025-01-23 | 2025-01-22 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 3,323 | $101.1K | -88.2% | open → |
| 2025-01-30 | 2025-01-29 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 695 | $20.5K | -87.8% | open → |
| 2025-03-06 | 2025-03-04 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Gift | 6,667 | $0.00 | — | open → |
| 2025-03-06 | 2025-03-05 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,569 | $139.8K | -85.7% | open → |
| 2025-03-06 | 2025-03-04 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Gift | 6,667 | $0.00 | — | open → |
| 2025-06-18 | 2025-06-16 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $93.8K | -80.9% | open → |
| 2025-12-18 | 2025-12-16 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $122.4K | -85.3% | open → |
| 2025-11-18 | 2025-11-17 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $100.3K | -82.1% | open → |
| 2025-10-17 | 2025-10-16 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $126.1K | -85.8% | open → |
| 2025-07-18 | 2025-07-16 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $97.8K | -81.6% | open → |
| 2025-08-19 | 2025-08-18 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $139.0K | -87.1% | open → |
| 2025-09-12 | 2025-09-10 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 20,000 | $523.4K | -86.3% | open → |
| 2025-09-18 | 2025-09-16 | APLS Apellis Pharmaceuticals, Inc. | Officer General Counsel | Sale | 5,000 | $121.7K | -85.2% | open → |
